Status:
UNKNOWN
Efficacy of Botulinum Toxin Type A in Patients With Bladder Pain Syndrome/Intersticial Cystitis and Hunners' Lesions
Lead Sponsor:
Moscow State University of Medicine and Dentistry
Conditions:
Interstitial Cystitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The etiology of bladder pain syndrome is unknown. Therefore the management is directed to pain relief, as bladder pain is believed to drive both voiding frequency and nocturia. Botulinum toxin A has b...
Eligibility Criteria
Inclusion
- longer than 6 months of bladder pain syndrome/interstitial cystitis with Hunner Lesion(s) during cystoscopy
Exclusion
- Pregnancy
- neurologic diseases
- urinary tract infections
- bladder outlet obstruction
- previous pelvic radiotherapy
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2012
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01437579
Start Date
June 1 2011
End Date
June 1 2012
Last Update
September 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology department of moscow state university of medicine and dentistry
Moscow, Russia, 127206